Literature DB >> 9805186

Cyclophosphamide therapy in a patient with membranoproliferative glomerulonephritis and essential mixed cryoglobulinaemia.

M Abu-Shakra1, M J Hausmann, L Kachko, D Flusser, D Buskila, S Sukenik.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9805186     DOI: 10.1007/bf01450900

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  5 in total

1.  Use of plasmapheresis and partial plasma exchange in the management of patients with cryoglobulinemia.

Authors:  E M Berkman; J B Orlin
Journal:  Transfusion       Date:  1980 Mar-Apr       Impact factor: 3.157

2.  Type II essential mixed cryoglobulinaemia: presentation, treatment and outcome in 13 patients.

Authors:  A H Frankel; D R Singer; C G Winearls; D J Evans; A J Rees; C D Pusey
Journal:  Q J Med       Date:  1992-02

3.  Membranoproliferative glomerulonephritis associated with hepatitis C virus infection.

Authors:  R J Johnson; D R Gretch; H Yamabe; J Hart; C E Bacchi; P Hartwell; W G Couser; L Corey; M H Wener; C E Alpers
Journal:  N Engl J Med       Date:  1993-02-18       Impact factor: 91.245

Review 4.  Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients.

Authors:  P D Gorevic; H J Kassab; Y Levo; R Kohn; M Meltzer; P Prose; E C Franklin
Journal:  Am J Med       Date:  1980-08       Impact factor: 4.965

5.  Successful cyclophosphamide treatment of cryoglobulinemic membranoproliferative glomerulonephritis associated with hepatitis C virus infection.

Authors:  R J Quigg; M Brathwaite; D F Gardner; D R Gretch; S Ruddy
Journal:  Am J Kidney Dis       Date:  1995-05       Impact factor: 8.860

  5 in total
  1 in total

1.  Symptomatic and virological response to antiviral therapy in hepatitis C associated with extrahepatic complications of cryoglobulimia.

Authors:  Supriya Joshi; Magdalena Kuczynski; E Jenny Heathcote
Journal:  Dig Dis Sci       Date:  2007-04-06       Impact factor: 3.487

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.